FDA Inspection 756552 — Astellas Pharma Inc.
The FDA completed an inspection of Astellas Pharma Inc. on November 21, 2011 in Takaoka. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 21, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Takaoka (Japan)